Johannes Huelsenbeck

Author

Johannes Gutenberg University Mainz

Also Known As

HUELSENBECK Johannes, Huelsenbeck Johannes, J Huelsenbeck, J. Huelsenbeck, Johannes Huelsenbeck

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Heinrich Heine University Düsseldorf Medizinische Hochschule Hannover

About

Johannes Huelsenbeck is an author at Johannes Gutenberg University Mainz specializing in medicine, cell death, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	499
2	Cell Biology	4	4	196
3	Immunology	3	3	187
4	Natural Sciences	2	2	120
5	Biochemistry	2	2	120

Johannes Huelsenbeck

Publications

900

Citations

H-Index

Page 1

	Year	Citations
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy Jörg Fahrer, Stephan Maus, Frank Bruchertseifer, PLoS ONE	2014	135
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity Johannes Huelsenbeck, Christian Henninger, Arno Schad, Cell Death and Disease InflammationMedicineHarmful Doxorubicin EffectsImmunologyCardiovascular Pharmacology	2011	104
Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons Stefanie C. Huelsenbeck, Anne Schorr, Wynand P. Roos, Journal of Biological Chemistry	2012	84
Cellular stability of Rho‐GTPases glucosylated by <i>Clostridium difficile</i> toxin B Harald Genth, Johannes Huelsenbeck, Birgit Hartmann, FEBS Letters	2006	83
Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts Jörg Fahrer, Johannes Huelsenbeck, Henriette Jaurich, DNA repair Genome InstabilityDna DamageDna Double-strand BreaksDna ReplicationPathology	2014	78
Difference in the Cytotoxic Effects of Toxin B from<i>Clostridium difficile</i>Strain VPI 10463 and Toxin B from Variant<i>Clostridium difficile</i>Strain 1470 Johannes Huelsenbeck, Stefanie C. Dreger, Ralf Gerhard, Infection and Immunity ToxinologyToxin BApoptosisImmunologyCell Death	2006	70
The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity Christian Henninger, Johannes Huelsenbeck, Stefanie C. Huelsenbeck, Toxicology and Applied Pharmacology InflammationLiver PhysiologyPharmacologyHepatotoxicityPharmacotherapy	2012	62
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin Christian Henninger, Stefanie C. Huelsenbeck, Philip Wenzel, Pharmacological Research Heart FailureChronic Heart DamageCardiovascular DiseasePharmacologyCardiovascular Pharmacology	2014	55
Prevention of the cytopathic effect induced by <i>Clostridium difficile</i> Toxin B by active Rac1 Ismael Halabi-Cabezon, Johannes Huelsenbeck, Martin May, FEBS Letters	2008	51
Upregulation of the Immediate Early Gene Product RhoB by Exoenzyme C3 from <i>Clostridium limosum</i> and Toxin B from <i>Clostridium difficile</i> Johannes Huelsenbeck, Stefanie C. Dreger, Ralf Gerhard, Biochemistry Microbial PathogensToxin BTcdb-induced ApoptosisBacteriologyMolecular Biology	2007	50

Page 1